Analysis of maternal Fc gamma receptor IIIb isoantibodies using immunomagnetic negative selected neutrophils.

Fc‐gamma‐receptor‐IIIb dextran/Ficoll human neutrophil antigen‐1 immunomagnetic negative selection of neutrophils neonatal alloimmune neutropenia neutrophil isolation

Journal

Vox sanguinis
ISSN: 1423-0410
Titre abrégé: Vox Sang
Pays: England
ID NLM: 0413606

Informations de publication

Date de publication:
10 Apr 2024
Historique:
revised: 15 03 2024
received: 17 01 2024
accepted: 24 03 2024
medline: 10 4 2024
pubmed: 10 4 2024
entrez: 10 4 2024
Statut: aheadofprint

Résumé

The isolation of neutrophils and subsequent detection of anti-human neutrophil antigens (HNA) antibodies are crucial in clinical medicine for the diagnosis of autoimmune neutropenia, neonatal alloimmune neutropenia (NAIN) and transfusion-related acute lung injury (TRALI). This study reports two cases of maternal anti-Fc-gamma-receptor-IIIb (FcγRIIIb) isoimmunization without NAIN symptoms and compares the efficiency of immunomagnetic negative selection (IMNS) with traditional dextran/Ficoll for neutrophil isolation in HNA serological assays. Investigating two cases of maternal anti-FcγRIIIb isoimmunization, neutrophils from three donors were isolated from 8 mL of whole blood using IMNS and dextran/Ficoll. Serological assays included the granulocyte agglutination and immunofluorescence test, monoclonal antibody immobilization of granulocyte antigens and the LABScreen Multi (One Lambda). IMNS and dextran/Ficoll were compared in terms of cell yield, viability, time, cost and purity. Maternal anti-FcγRIIIb isoantibodies with FCGR3B gene deletion were detected in both cases. Newborns and fathers exhibited specific gene combinations: FCGR3B*02/FCGR3B*02 (Case 1) and FCGR3B*02/FCGR3B*03 (Case 2). IMNS outperformed dextran/Ficoll, yielding four times more neutrophils (average neutrophil counts: 18.5 × 10 Two cases of maternal anti-FcγRIIIb isoantibodies, unrelated to NAIN, were identified. Although neutropenia has not been described in these cases, we emphasize the importance of identifying asymptomatic cases with the potential for severe neutropenia. Additionally, IMNS is introduced as a rapid, high-yield, high-purity neutrophil isolation technique, beneficial for serological assays detecting anti-HNA antibodies.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
The isolation of neutrophils and subsequent detection of anti-human neutrophil antigens (HNA) antibodies are crucial in clinical medicine for the diagnosis of autoimmune neutropenia, neonatal alloimmune neutropenia (NAIN) and transfusion-related acute lung injury (TRALI). This study reports two cases of maternal anti-Fc-gamma-receptor-IIIb (FcγRIIIb) isoimmunization without NAIN symptoms and compares the efficiency of immunomagnetic negative selection (IMNS) with traditional dextran/Ficoll for neutrophil isolation in HNA serological assays.
MATERIALS AND METHODS METHODS
Investigating two cases of maternal anti-FcγRIIIb isoimmunization, neutrophils from three donors were isolated from 8 mL of whole blood using IMNS and dextran/Ficoll. Serological assays included the granulocyte agglutination and immunofluorescence test, monoclonal antibody immobilization of granulocyte antigens and the LABScreen Multi (One Lambda). IMNS and dextran/Ficoll were compared in terms of cell yield, viability, time, cost and purity.
RESULTS RESULTS
Maternal anti-FcγRIIIb isoantibodies with FCGR3B gene deletion were detected in both cases. Newborns and fathers exhibited specific gene combinations: FCGR3B*02/FCGR3B*02 (Case 1) and FCGR3B*02/FCGR3B*03 (Case 2). IMNS outperformed dextran/Ficoll, yielding four times more neutrophils (average neutrophil counts: 18.5 × 10
CONCLUSION CONCLUSIONS
Two cases of maternal anti-FcγRIIIb isoantibodies, unrelated to NAIN, were identified. Although neutropenia has not been described in these cases, we emphasize the importance of identifying asymptomatic cases with the potential for severe neutropenia. Additionally, IMNS is introduced as a rapid, high-yield, high-purity neutrophil isolation technique, beneficial for serological assays detecting anti-HNA antibodies.

Identifiants

pubmed: 38597364
doi: 10.1111/vox.13631
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Informations de copyright

© 2024 International Society of Blood Transfusion.

Références

Wang Y, Jönsson F. Expression, role, and regulation of neutrophil Fcγ receptors. Front Immunol. 2019;10:1958.
Minguela A, Salido EJ, Soto‐Ramírez MF, Olga MA, Leal JD, García‐Garay MC, et al. Low‐affinity immunoglobulin gamma fc region receptor III‐B (FcγRIIIB, CD16B) deficiency in patients with blood and immune system disorders. Br J Haematol. 2021;195:743–747.
Fall AKDJ, Courtin D, Adamou R, Edslev S, Hansen A, Domingo N, et al. Fc gamma receptor IIIB NA1/NA2/SH polymorphisms are associated with malaria susceptibility and antibody levels to P. falciparum merozoite antigens in Beninese children. Int J Mol Sci. 2022;23:14882.
Flesch BK, Reil A. Molecular genetics of the human neutrophil antigens. Transfus Med Hemother. 2018;45:300–309.
de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE. Neutrophil fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood. 1995;86:2403–2413.
van den Tooren‐de Groot R, Ottink M, Huiskes E, van Rossum A, van der Voorn B, Slomp J, et al. Management and outcome of 35 cases with foetal/neonatal alloimmune neutropenia. Acta Paediatr. 2014;103:e467–e474.
Abbas SA, Lopes LB, Moritz E, Martins JO, Chiba AK, Kunioshi AM, et al. Serologic and molecular studies to identify neonatal alloimmune neutropenia in a cohort of 10,000 neonates. Br J Haematol. 2021;192:778–784.
Browne T, Dearman RJ, Poles A. Human neutrophil antigens: nature, clinical significance and detection. Int J Immunogenet. 2021;48:145–156.
Kissel K, Hofmann C, Gittinger FS, Daniels G, Bux J. HNA‐1a, HNA‐1b, and HNA‐1c (NA1, NA2, SH) frequencies in African and American Blacks and in Chinese. Tissue Antigens. 2000;56:143–148.
Flesch BK, Doose S, Siebert R, Ntambi E, Neppert J. FCGR3 variants and expression of human neutrophil antigen‐1a, −1b, and −1c in the populations of northern Germany and Uganda. Transfusion. 2002;42:469–475.
Cattaneo A, Liguori M, Trombetta E, Ceriotti F, Pugni L, Ronchi A, et al. Neonatal alloimmune neutropenia: diagnosis and management of 31 Italian patients. Blood Transfus. 2023;21:227–234.
Fromont P, Bettaieb A, Skouri H, Floch C, Poulet E, Duedari N, et al. Frequency of the polymorphonuclear neutrophil fc gamma receptor III deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia. Blood. 1992;79:2131–2134.
Valle Del Barrio B, Maya‐Enero S, Rodríguez‐Sevilla JJ, Canals Surís C, Bosch Llobet A, López‐Vílchez MÁ. Neonatal immune neutropenia due to isoantibodies against the granulocyte receptor FcγRIIIb. Transfus Med Hemother. 2021;48:259–262.
Żupańska B, Uhrynowska M, Guz K, Maślanka K, Brojer E, Czestyńska M, et al. The risk of antibody formation against HNA1a and HNA1b granulocyte antigens during pregnancy and its relation to neonatal neutropenia. Transfus Med. 2001;11:377–382.
Fioredda F, Skokowa J, Tamary H, Spanoudakis M, Farruggia P, Almeida A, et al. The European guidelines on diagnosis and Management of Neutropenia in adults and children: a consensus between the European Hematology Association and the EuNet‐INNOCHRON COST action. Hemasphere. 2023;7:e872 Erratum in: Hemasphere. 2023;7:e897.
Bierling P, Bux J, Curtis B, Flesch B, Fung L, Lucas G, et al. Recommendations of the ISBT working party on granulocyte immunobiology for leucocyte antibody screening in the investigation and prevention of antibody‐mediated transfusion‐related acute lung injury. Vox Sang. 2009;96:266–269.
Quach A, Ferrante A. The application of dextran sedimentation as an initial step in neutrophil purification promotes their stimulation, due to the presence of monocytes. J Immunol Res. 2017;2017:1254792.
Zieliński M, Zielińska H, Moszkowska G, Dȩbska‐Ślizień A, Rutkowski B, Trzonkowski P. Modified flow cytometry crossmatch detecting alloantibody‐related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients. Transplant Proc. 2013;45:88–94.
Martins JO, Moritz E, Abbas SA, Lopes LB, Barros MMO, Chiba AK, et al. Antibodies against human neutrophil antigens in non‐transfused women with red blood cell alloimmunisation induced by pregnancy. Blood Transfus. 2021;19:479–486.
Reil A, Bux J. Geno‐ and phenotyping of human neutrophil antigens. Methods Mol Biol. 2015;1310:193–203.
Nguyen XD, Flesch B, Sachs UJ, Kroll H, Klüter H, Müller‐Steinhardt M. Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test. Transfusion. 2009;49:2700–2708.
Bai M, Grieshaber‐Bouyer R, Wang J, Schmider AB, Wilson ZS, Zeng L, et al. CD177 modulates human neutrophil migration through activation‐mediated integrin and chemoreceptor regulation. Blood. 2017;130:2092–2100.
Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID‐19 acute respiratory distress syndrome. Blood. 2020;136:1169–1179.

Auteurs

Juliana Oliveira Martins (JO)

Department of Clinical and Experimental Oncology, Universidade Federal de São Paulo, UNIFESP, São Paulo, Brazil.

Elyse Moritz (E)

Department of Clinical and Experimental Oncology, Universidade Federal de São Paulo, UNIFESP, São Paulo, Brazil.

Samira Ali Abbas (SA)

Department of Clinical and Experimental Oncology, Universidade Federal de São Paulo, UNIFESP, São Paulo, Brazil.
Hospital Geral de Guarulhos, São Paulo, Brazil.

Behnaz Bayat (B)

Institute for Clinical Immunology, Transfusion Medicine, and Haemostasis, Justus Liebig University, Giessen, Germany.

Melca Maria Oliveira Barros (MMO)

Department of Clinical and Experimental Oncology, Universidade Federal de São Paulo, UNIFESP, São Paulo, Brazil.

Renato de Marco (R)

Instituto de Imunogenética, IGEN, São Paulo, Brazil.

Renata Fantini Machado (RF)

Instituto de Imunogenética, IGEN, São Paulo, Brazil.

José Orlando Bordin (JO)

Department of Clinical and Experimental Oncology, Universidade Federal de São Paulo, UNIFESP, São Paulo, Brazil.

Classifications MeSH